- Home
- SWZ vs EPIX Comparison
SWZ vs EPIX Comparison
Compare SWZ & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWZ
- EPIX
- Stock Information
- Founded
- SWZ 1986
- EPIX 2009
- Country
- SWZ United States
- EPIX Canada
- Employees
- SWZ N/A
- EPIX N/A
- Industry
- SWZ Finance Companies
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- SWZ Finance
- EPIX Health Care
- Exchange
- SWZ Nasdaq
- EPIX Nasdaq
- Market Cap
- SWZ 79.1M
- EPIX 75.9M
- IPO Year
- SWZ N/A
- EPIX N/A
- Fundamental
- Price
- SWZ $6.12
- EPIX $1.93
- Analyst Decision
- SWZ
- EPIX Hold
- Analyst Count
- SWZ 0
- EPIX 3
- Target Price
- SWZ N/A
- EPIX $2.00
- AVG Volume (30 Days)
- SWZ 14.2K
- EPIX 474.6K
- Earning Date
- SWZ 01-01-0001
- EPIX 08-13-2025
- Dividend Yield
- SWZ 6.59%
- EPIX N/A
- EPS Growth
- SWZ N/A
- EPIX N/A
- EPS
- SWZ N/A
- EPIX N/A
- Revenue
- SWZ N/A
- EPIX N/A
- Revenue This Year
- SWZ N/A
- EPIX N/A
- Revenue Next Year
- SWZ N/A
- EPIX N/A
- P/E Ratio
- SWZ N/A
- EPIX N/A
- Revenue Growth
- SWZ N/A
- EPIX N/A
- 52 Week Low
- SWZ $7.12
- EPIX $1.40
- 52 Week High
- SWZ $8.57
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- SWZ 46.11
- EPIX 65.49
- Support Level
- SWZ $6.03
- EPIX $1.90
- Resistance Level
- SWZ $6.20
- EPIX $1.93
- Average True Range (ATR)
- SWZ 0.06
- EPIX 0.01
- MACD
- SWZ 0.00
- EPIX -0.00
- Stochastic Oscillator
- SWZ 44.74
- EPIX 85.71
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.